This personalized guidance increases your odds of selecting a treatment you'll stick with and that delivers measurable, sustainable weight loss aligned with your biology
PYY(3-36) itself has been studied as a monotherapy for weight loss when delivered nasally in human volunteers, but the efficacy in terms of weight loss was limited by dose-dependent adverse events in the form of nausea and vomiting [44], possibly because this preparation and method of delivery led to a rapid release of PYY(3-36) to supraphysiological levels
Our Final Thoughts The GLP-1 microdosing trend, while born from a desire for solutions, isnt without risk
But the nature of these prescription medicationswhich have to be stored within a specific temperature range and self-administered via single-use injection pen on a weekly basispresents some challenges for travelers
Now, with advances in medical research and the growing list of drugs available to treat excess weight and obesity, treatment can and should be personalized
Calabrese EJ, Kozumbo WJ